N-(4-chlorophenethyl)-2-cyanoacetamide | 195884-25-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-chlorophenethyl)-2-cyanoacetamide
• 英文别名: N-[2-(4-chlorophenyl)ethyl]-2-cyanoacetamide
• CAS: 195884-25-4
• 化学式: C₁₁H₁₁ClN₂O
• 分子量: 222.674
• InChiKey: DCMOVOMRIIJXOD-UHFFFAOYSA-N

物化性质

• 沸点：
  459.2±35.0 °C(Predicted)
• 密度：
  1.216±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  52.9
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(4-chlorophenethyl)-2-cyanoacetamide 、 5-氯-2-氟硝基苯 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 1.17h， 生成
  参考文献：
  名称：

  One-Pot Synthesis of 2-Amino-indole-3-carboxamide and Analogous

  摘要：

  An efficient one-pot, two-step solution-phase synthetic method was developed to synthesize twenty-three 2-amino-indole-3-carboxamides (3) from 2-halonitrobenzene (1) or heterocyclic analogous and cyanoacetamides (2). In this sequence, first, intermediate 2cyano-2-(2-nitrophenyl)acetamide (4) was generated under basic condition via S(NAr) reaction; after direct addition of hydrochloric acid solution, FeCl(3), and Zn powder, indole 3 was generated via reduction/cyclization process.

  DOI：

  10.1021/co100040z
• 作为产物：
  描述：

  4-氯苯乙胺 、 氰乙酸甲酯 生成 N-(4-chlorophenethyl)-2-cyanoacetamide
  参考文献：
  名称：

  Cyanoacetamides (IV): Versatile One-Pot Route to 2-Quinoline-3-carboxamides

  摘要：

  Cyanoacetic acid derivatives are the starting materials for a plethora of multicomponent reaction (MCR) scaffolds. Herein, we describe scope of a valuable general protocol for the synthesis of arrays of 2-aminoquinoline-3-carboxamides from cyanoacetamides and 2-aminobenzaldehydes or heterocyclic derivatives via a Friedlander reaction variation. In many cases, the reactions involve a very convenient work up by simple precipitation and filtration. More than 40 new products are described. We foresee our protocol and the resulting derivatives becoming very valuable to greatly expanding the scaffold space of cyanoacetamide derivatives.

  DOI：

  10.1021/co3000133

文献信息

• [EN] NOVEL ARGINASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS D'ARGINASE
  申请人：UNIV GRONINGEN

  公开号：WO2020249821A1

  公开（公告）日：2020-12-17

  The present invention relates to novel arginase inhibitors of formula (I). These novel compounds are useful in the treatment of diseases that are associated with arginase activity, such as asthma, allergic rhinitis and COPD (chronic obstructive pulmonary disease).

  本发明涉及式(I)的新型精氨酸酶抑制剂。这些新型化合物在治疗与精氨酸酶活性相关的疾病方面具有用途，如哮喘、过敏性鼻炎和慢性阻塞性肺疾病（COPD）。
• Cyanoacetamide MCR (III): Three-Component Gewald Reactions Revisited
  作者：Kan Wang、Dabin Kim、Alexander Dömling

  DOI：10.1021/cc9001586

  日期：2010.1.11

  Cyanoacetic acid derivatives are the starting materials for a plethora of multicomponent reaction (MCR) scaffolds. Here we describe valuable general protocols for the synthesis of arrays of 2-aminothiophene-3-carboxamides from cyanoacetamides, aldehydes or ketones, and sulfur via a Gewald-3CR variation. In many cases the reactions involve a very convenient work up by simple precipitation in water and filtration

  氰基乙酸衍生物是大量多组分反应（MCR）支架的起始材料。在这里，我们描述了通过Gewald-3CR变异体从氰基乙酰胺，醛或酮和硫合成2-氨基噻吩-3-羧酰胺阵列的有价值的通用协议。在许多情况下，通过在水中简单沉淀和过滤，反应涉及非常方便的后处理。描述了40多种新产品。我们预见到我们的方案及其产生的衍生物对于极大地扩展氰基乙酰胺衍生物的MCR支架空间将变得非常有价值。
• Thieno[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative Inhibits <scp>d</scp>-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells
  作者：Zhangping Xiao、Angelina Osipyan、Shanshan Song、Deng Chen、Reinder A. Schut、Ronald van Merkerk、Petra E. van der Wouden、Robbert H. Cool、Wim J. Quax、Barbro N. Melgert、Gerrit J. Poelarends、Frank J. Dekker

  DOI：10.1021/acs.jmedchem.1c01598

  日期：2022.2.10

  The homologous cytokines macrophage migration inhibitory factor (MIF) and d-dopachrome tautomerase (d-DT or MIF2) play key roles in cancers. Molecules binding to the MIF tautomerase active site interfere with its biological activity. In contrast, the lack of potent MIF2 inhibitors hinders the exploration of MIF2 as a drug target. In this work, screening of a focused compound collection enabled the

  同源细胞因子巨噬细胞迁移抑制因子 (MIF) 和d-多巴色素互变异构酶 ( d -DT 或 MIF2) 在癌症中起关键作用。与 MIF 互变异构酶活性位点结合的分子会干扰其生物活性。相比之下，缺乏有效的 MIF2 抑制剂阻碍了将 MIF2 作为药物靶点的探索。在这项工作中，筛选集中的化合物集合能够识别 MIF2 互变异构酶抑制剂 R110。随后的优化为抑制剂5d提供了对 MIF2 互变异构酶活性的 IC 50为 1.0 μM 和对 MIF 的高选择性。5天抑制二维 (2D) 和三维 (3D) 细胞培养物中非小细胞肺癌细胞的增殖，这可以通过失活促分裂原活化蛋白激酶 (MAPK) 诱导细胞周期停滞来解释) 途径。因此，我们发现并表征了 MIF2 抑制剂 ( 5d ) 在细胞模型系统中具有改善的抗增殖活性，这表明靶向 MIF2 在癌症治疗中的潜力。
• Naphthyridine derivatives, their methods of preparation and
  申请人：Laboratoires UPSA

  公开号：US05663181A1

  公开（公告）日：1997-09-02

  The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as drugs having antiproliferative properties and affording an effective treatment for diseases such as cancer, psoriasis, atherosclerosis, restenosis phenomena or any other pathological condition due to cell proliferation.

  本发明涉及公式##STR1##的衍生物及其加合盐，并且涉及它们在治疗学中的应用，特别是作为具有抗增殖性质的药物，为癌症、银屑病、动脉硬化、再狭窄现象或任何由细胞增殖引起的病理状况提供有效治疗。
• Discovery of chromenes as inhibitors of macrophage migration inhibitory factor
  作者：Tjie Kok、Hannah Wapenaar、Kan Wang、Constantinos G. Neochoritis、Tryfon Zarganes-Tzitzikas、Giordano Proietti、Nikolaos Eleftheriadis、Katarzyna Kurpiewska、Justyna Kalinowska-Tłuścik、Robbert H. Cool、Gerrit J. Poelarends、Alexander Dömling、Frank J. Dekker

  DOI：10.1016/j.bmc.2017.12.032

  日期：2018.3

  Macrophage migration inhibitory factor (MIF) is an essential signaling cytokine with a key role in the immune system. Binding of MIF to its molecular targets such as, among others, the cluster of differentiation 74 (CD74) receptor plays a key role in inflammatory diseases and cancer. Therefore, the identification of MIF binding compounds gained importance in drug discovery. In this study, we aim to discover novel MIF binding compounds by screening of a focused compound collection for inhibition of its tautomerase enzyme activity. Inspired by the known chromen-4-one inhibitor Orita-13, a focused collection of compounds with a chromene scaffold was screened for MIF binding. The library was synthesized using versatile cyanoacetamide chemistry to provide diversely substituted chromenes. The screening provided inhibitors with IC50's in the low micromolar range. Kinetic evaluation suggested that the inhibitors were reversible and did not bind in the binding pocket of the substrate. Thus, we discovered novel inhibitors of the MIF tautomerase activity, which may ultimately support the development of novel therapeutic agents against diseases in which MIF is involved. (C) 2017 Elsevier Ltd. All rights reserved.